An action plan has been developed for the implementation of serological tests to study immunity to the SARS CoV-2 virus in Azerbaijan.
The tests will be conducted on a voluntary basis among randomly selected groups of the population, Qadin.Net reports quoting Milli.az. For this purpose, randomly selected persons will be called from the call center. A specially trained bleeding nurse will be sent from the local polyclinic to the home of the person who agreed to take the test. It is enough to take only 3-5 ml of blood sample from a vein for examination. Blood samples will be delivered to the laboratory for analysis as soon as possible. Medical and statistical analysis of the results of the analysis will be carried out by specialists, and the public will be informed about the final results. Every volunteer who analyzes will be able to get their result. In addition, a general blood test can be performed at the request of the citizen.
At the initial stage, the research is planned to be conducted in Baku, Sumgayit and Ganja. The research will be carried out with reagents manufactured by the German company EUROIMMUN, imported by the state.
Note that after a person is infected with a virus, the body produces protective proteins - antibodies. It takes some time for antibodies against viruses to form. On the other hand, the retention of the formed immunity in the body may be temporary, not permanent. Therefore, it is necessary to conduct serological tests as soon as possible and obtain results.